These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Betulinic acid derivatives as human immunodeficiency virus type 2 (HIV-2) inhibitors. Dang Z; Lai W; Qian K; Ho P; Lee KH; Chen CH; Huang L J Med Chem; 2009 Dec; 52(23):7887-91. PubMed ID: 19526990 [TBL] [Abstract][Full Text] [Related]
8. Anti-AIDS agents. 78. Design, synthesis, metabolic stability assessment, and antiviral evaluation of novel betulinic acid derivatives as potent anti-human immunodeficiency virus (HIV) agents. Qian K; Yu D; Chen CH; Huang L; Morris-Natschke SL; Nitz TJ; Salzwedel K; Reddick M; Allaway GP; Lee KH J Med Chem; 2009 May; 52(10):3248-58. PubMed ID: 19388685 [TBL] [Abstract][Full Text] [Related]
9. Anti-AIDS agents 49. Synthesis, anti-HIV, and anti-fusion activities of IC9564 analogues based on betulinic acid. Sun IC; Chen CH; Kashiwada Y; Wu JH; Wang HK; Lee KH J Med Chem; 2002 Sep; 45(19):4271-5. PubMed ID: 12213068 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and structure activity relationship analysis of new betulinic acid derivatives as potent HIV inhibitors. Zhao Y; Chen CH; Morris-Natschke SL; Lee KH Eur J Med Chem; 2021 Apr; 215():113287. PubMed ID: 33639343 [TBL] [Abstract][Full Text] [Related]
11. 3-O-Glutaryl-dihydrobetulin and related monoacyl derivatives as potent anti-HIV agents. Kashiwada Y; Sekiya M; Ikeshiro Y; Fujioka T; Kilgore NR; Wild CT; Allaway GP; Lee KH Bioorg Med Chem Lett; 2004 Dec; 14(23):5851-3. PubMed ID: 15501054 [TBL] [Abstract][Full Text] [Related]
12. Anti-AIDS agents 81. Design, synthesis, and structure-activity relationship study of betulinic acid and moronic acid derivatives as potent HIV maturation inhibitors. Qian K; Kuo RY; Chen CH; Huang L; Morris-Natschke SL; Lee KH J Med Chem; 2010 Apr; 53(8):3133-41. PubMed ID: 20329730 [TBL] [Abstract][Full Text] [Related]
13. Anti-AIDS agents, 11. Betulinic acid and platanic acid as anti-HIV principles from Syzigium claviflorum, and the anti-HIV activity of structurally related triterpenoids. Fujioka T; Kashiwada Y; Kilkuskie RE; Cosentino LM; Ballas LM; Jiang JB; Janzen WP; Chen IS; Lee KH J Nat Prod; 1994 Feb; 57(2):243-7. PubMed ID: 8176401 [TBL] [Abstract][Full Text] [Related]
14. Anti-human immunodeficiency virus activity of YK-FH312 (a betulinic acid derivative), a novel compound blocking viral maturation. Kanamoto T; Kashiwada Y; Kanbara K; Gotoh K; Yoshimori M; Goto T; Sano K; Nakashima H Antimicrob Agents Chemother; 2001 Apr; 45(4):1225-30. PubMed ID: 11257038 [TBL] [Abstract][Full Text] [Related]
16. Chemistry, biological activity, and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infection. Cichewicz RH; Kouzi SA Med Res Rev; 2004 Jan; 24(1):90-114. PubMed ID: 14595673 [TBL] [Abstract][Full Text] [Related]
17. Ionic derivatives of betulinic acid exhibit antiviral activity against herpes simplex virus type-2 (HSV-2), but not HIV-1 reverse transcriptase. Visalli RJ; Ziobrowski H; Badri KR; He JJ; Zhang X; Arumugam SR; Zhao H Bioorg Med Chem Lett; 2015 Aug; 25(16):3168-71. PubMed ID: 26112446 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of 3-O-acyl/3-benzylidene/3-hydrazone/3-hydrazine/17-carboxyacryloyl ester derivatives of betulinic acid as anti-angiogenic agents. Mukherjee R; Jaggi M; Rajendran P; Srivastava SK; Siddiqui MJ; Vardhan A; Burman AC Bioorg Med Chem Lett; 2004 Jun; 14(12):3169-72. PubMed ID: 15149668 [TBL] [Abstract][Full Text] [Related]
19. Structure and Anti-HIV Activity of Betulinic Acid Analogues. Huang QX; Chen HF; Luo XR; Zhang YX; Yao X; Zheng X Curr Med Sci; 2018 Jun; 38(3):387-397. PubMed ID: 30074203 [TBL] [Abstract][Full Text] [Related]
20. Fluorinated betulinic acid derivatives and evaluation of their anti-HIV activity. Li J; Goto M; Yang X; Morris-Natschke SL; Huang L; Chen CH; Lee KH Bioorg Med Chem Lett; 2016 Jan; 26(1):68-71. PubMed ID: 26598461 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]